Lipocine Inc. Research And Development Expense

• Lipocine Inc. showed an increase of +16.8% in Research And Development Expense from 2024 to 2025.
• This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 14 years of available data (2012 to 2025), Lipocine Inc.'s Research And Development Expense has grown by 276.3%.
• Historical annual values: Fiscal year 2025: $8.58 million | Fiscal year 2024: $7.35 million | Fiscal year 2023: $10.18 million | Fiscal year 2022: $8.56 million | Fiscal year 2021: $7.67 million | Fiscal year 2020: $9.75 million | Fiscal year 2019: $7.47 million | Fiscal year 2018: $6.46 million | Fiscal year 2017: $11.00 million | Fiscal year 2016: $8.08 million | Fiscal year 2015: $12.58 million | Fiscal year 2014: $15.48 million | Fiscal year 2013: $5.12 million | Fiscal year 2012: $2.28 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026